Literature DB >> 24901173

Simple prognostic indicators using macroscopic features and age in advanced gastric cancer.

Keishi Yamashita, Shinichi Sakuramoto, Natsuya Katada, Shiro Kikuchi, Masahiko Watanabe.   

Abstract

BACKGROUND/AIM: Macroscopic features and age may be important prognostic factors that discriminate survival among clinical conditions requiring different therapeutic strategies of advanced gastric cancer (AGC), and this study aimed to identify their clinical relevance.
METHODOLOGY: A total of 232 AGC patients who had Surgical T2b or beyond was enrolled to identify clinical indicators, including macroscopic features in combination with age.
RESULTS: Macroscopic features were divided into 3 categories (types I/II/V, III, and IV), which included stage IV in 24%, 53%, and 72% (P < 0.0001), respectively. Macroscopic features (P < 0.0001), histological features (P = 0.025), and pathological infiltration type (P = 0.0003) were all univariate prognostic factors, as well as stage (P < 0.0001) and age (P = 0.009). However, the multivariate proportional hazards model found that macroscopic features (P = 0.0013) and age (P = 0.0091) were the only factors independent of stage (P <0.0001). Both factors clearly classified the patients into 4 groups (young type 1/II/V (group 1), elderly type I/II/V (group 2), type III and young type IV (group 3), and elderly type IV (group 4) with different prognoses.
CONCLUSIONS: Macroscopic features and age were simple indicators of prognosis in AGC. Both factors may have great potential to develop prognostic categories that effectively classify AGC into categories requiring different therapeutic strategies.

Entities:  

Mesh:

Year:  2014        PMID: 24901173

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  4 in total

1.  DNA diagnosis of peritoneal fluid cytology test by CDO1 promoter DNA hypermethylation in gastric cancer.

Authors:  Hideki Ushiku; Keishi Yamashita; Akira Ema; Naoko Minatani; Mariko Kikuchi; Ken Kojo; Keigo Yokoi; Toshimichi Tanaka; Nobuyuki Nishizawa; Satoru Ishii; Kei Hosoda; Hiromitsu Moriya; Hiroaki Mieno; Natsuya Katada; Shiro Kikuchi; Hiroshi Katoh; Masahiko Watanabe
Journal:  Gastric Cancer       Date:  2017-02-27       Impact factor: 7.370

2.  Impact of AADAC gene expression on prognosis in patients with Borrmann type III advanced gastric cancer.

Authors:  Yufei Wang; Tianyi Fang; Yimin Wang; Xin Yin; Lei Zhang; Xinghai Zhang; Daoxu Zhang; Yao Zhang; Xibo Wang; Hao Wang; Yingwei Xue
Journal:  BMC Cancer       Date:  2022-06-09       Impact factor: 4.638

3.  Limited significance of curative surgery in Borrmann type IV gastric cancer.

Authors:  Eun Young Kim; Han Mo Yoo; Kyo Young Song; Cho Hyun Park
Journal:  Med Oncol       Date:  2016-06-01       Impact factor: 3.064

4.  Macroscopic appearance of Type IV and giant Type III is a high risk for a poor prognosis in pathological stage II/III advanced gastric cancer with postoperative adjuvant chemotherapy.

Authors:  Keishi Yamashita; Akira Ema; Kei Hosoda; Hiroaki Mieno; Hiromitsu Moriya; Natsuya Katada; Masahiko Watanabe
Journal:  World J Gastrointest Oncol       Date:  2017-04-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.